Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

ADAMA Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

ADAMA şirketinin toplam hissedar öz sermayesi CN¥21.0B ve toplam borcu CN¥18.6B olup, bu da borç-öz sermaye oranını 88.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥52.9B ve CN¥31.9B dir. ADAMA 'in FAVÖK'ü CN¥6.3M faiz karşılama oranı 0 dur. Şirketin CN¥4.1B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

88.6%

Borç/özkaynak oranı

CN¥18.59b

Borç

Faiz karşılama oranı	0.008x
Nakit	CN¥4.08b
Eşitlik	CN¥20.98b
Toplam yükümlülükler	CN¥31.87b
Toplam varlıklar	CN¥52.85b

Son finansal sağlık güncellemeleri

ADAMA (SZSE:000553) Has No Shortage Of Debt

Aug 20

Does ADAMA (SZSE:000553) Have A Healthy Balance Sheet?

Mar 01

Recent updates

Insufficient Growth At ADAMA Ltd. (SZSE:000553) Hampers Share Price

Sep 30

ADAMA (SZSE:000553) Has No Shortage Of Debt

Aug 20

ADAMA Ltd.'s (SZSE:000553) 26% Dip In Price Shows Sentiment Is Matching Revenues

Jun 19

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 000553 'nin kısa vadeli varlıkları ( CN¥27.7B ) kısa vadeli yükümlülüklerini ( CN¥17.7B ) aşıyor.

Uzun Vadeli Yükümlülükler: 000553 şirketinin kısa vadeli varlıkları ( CN¥27.7B ) uzun vadeli yükümlülüklerini ( CN¥14.2B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 000553 'nin net borç/öz sermaye oranı ( 69.2% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 000553 şirketinin borç/öz sermaye oranı son 5 yılda 51.6% seviyesinden 88.6% seviyesine yükseldi.

Borç Kapsamı: 000553 'nin borcu işletme nakit akışı ( 23.7% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 000553 'in borcuna ilişkin faiz ödemeleri EBIT ( 0 x kapsam) tarafından iyi karşılanmıyor.

ADAMA Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

ADAMA (SZSE:000553) Has No Shortage Of Debt

Does ADAMA (SZSE:000553) Have A Healthy Balance Sheet?

Recent updates

ADAMA Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Insufficient Growth At ADAMA Ltd. (SZSE:000553) Hampers Share Price

ADAMA (SZSE:000553) Has No Shortage Of Debt

High number of new directors

ADAMA Ltd. Appoints Gaël Hili as Its President Effective October 1, 2024

ADAMA Ltd. Appoints Brand Alexandra as Ordinary Director

ADAMA Ltd. to Report First Half, 2024 Results on Aug 29, 2024

ADAMA Ltd.'s (SZSE:000553) 26% Dip In Price Shows Sentiment Is Matching Revenues

These Return Metrics Don't Make ADAMA (SZSE:000553) Look Too Strong

ADAMA Ltd. Appoints Tan Hengde and Liu Hongsheng as Non-Independent Directors

First quarter 2024 earnings released: CN¥0.098 loss per share (vs CN¥0.036 profit in 1Q 2023)

ADAMA Launches New Cereal Fungicide Avastel for Superior Disease Control and Long-lasting Protection

ADAMA Ltd. Launches Maganic®

ADAMA Ltd Launches New Multi-Crop, Broad Spectrum Fungicide Maxentis® for Improved Disease Control and Increased Yield

ADAMA Ltd. Launches New Cereal Fungicide Forapro® for Supercharged Disease Control and Higher Yields

ADAMA Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Benign Growth For ADAMA Ltd. (SZSE:000553) Underpins Its Share Price

ADAMA Ltd. Announces Executive Appointments

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Does ADAMA (SZSE:000553) Have A Healthy Balance Sheet?

ADAMA Ltd. Expands Use of New Environmentally Friendly One-Liter Containers

Price target decreased by 20% to CN¥7.00

ADAMA Ltd. to Bring Innovation to European Molluscicide Segment with Novel Active Ingredient Feralla®

ADAMA Ltd. Launches Five New Products Across Europe

ADAMA Ltd. to Report Fiscal Year 2023 Results on Mar 27, 2024

ADAMA Ltd.(SZSE:000553) dropped from Shenzhen Stock Exchange Component Index

Third quarter 2023 earnings released: CN¥0.34 loss per share (vs CN¥0.015 profit in 3Q 2022)

ADAMA Ltd. Expands Availability of Apresa® in South America, Highly Effective Herbicide for Soybean, Corn and Other Crops

Price target decreased by 15% to CN¥8.80

ADAMA Ltd. Launches First Off-Patent CCTPR Based Offerings in India

Price target decreased by 8.8% to CN¥10.30

Second quarter 2023 earnings released

ADAMA Ltd. Provides Earnings Guidance for the First Half Year of 2023

ADAMA Ltd. Announces Implementation of Final Cash Dividend for 2022, Payable on 06 June 2023

Price target increased by 8.7% to CN¥11.29

Consensus EPS estimates fall by 23%, revenue upgraded

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

ADAMA Ltd Announces Executive Changes

ADAMA Ltd. Provides Earnings Guidance for the Year 2022

High number of new and inexperienced directors

Price target decreased to CN¥11.13

Consensus forecasts updated

Third quarter 2022 earnings released: EPS: CN¥0.015 (vs CN¥0.17 loss in 3Q 2021)

High number of new and inexperienced directors

Second quarter 2022 earnings released

ADAMA Ltd. to Report Q2, 2022 Results on Aug 29, 2022

Consensus forecasts updated

Adama Ltd. Implements 2021 Final Profit Distribution Plan for B Shares, Payable on 09 June 2022

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations

Price target decreased to CN¥10.05

High number of new and inexperienced directors

ADAMA Ltd. Approves Cash Dividend for the Year 2021

ADAMA Ltd Announces Appointment of Shahar Florence as Chief Financial Officer

ADAMA Ltd., Annual General Meeting, Apr 21, 2022

Full year 2021 earnings: EPS exceeds analyst expectations

ADAMA Ltd. Proposes Cash Dividend for 2021

Consensus forecasts updated

ADAMA Ltd. Provides Earnings Guidance for the Fourth Quarter and Full Year 2021

Third quarter 2021 earnings released: CN¥0.17 loss per share (vs CN¥0.009 profit in 3Q 2020)

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Consensus forecasts updated

ADAMA Ltd. to Introduce A Novel Proprietary Formulation Technology That Delivers Improved Penetration Efficiency and Excellent Systemic Movement in Plants, Resulting in Higher Efficacy in ADAMA's Prothioconazole-Based Products

ADAMA Ltd. (SZSE:000553) completed the acquisition of 51% stake in Jiangsu Kelinong Co., Ltd. from Jiangsu Huifeng Bio Agriculture Co., Ltd. (SZSE:002496).